These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 2004104

  • 1. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L.
    Biochim Biophys Acta; 1991 Feb 25; 1062(2):142-8. PubMed ID: 2004104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M.
    Biochim Biophys Acta; 1995 Mar 08; 1234(1):74-80. PubMed ID: 7880861
    [Abstract] [Full Text] [Related]

  • 4. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.
    Litzinger DC, Buiting AM, van Rooijen N, Huang L.
    Biochim Biophys Acta; 1994 Feb 23; 1190(1):99-107. PubMed ID: 8110825
    [Abstract] [Full Text] [Related]

  • 5. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.
    Klibanov AL, Maruyama K, Torchilin VP, Huang L.
    FEBS Lett; 1990 Jul 30; 268(1):235-7. PubMed ID: 2384160
    [Abstract] [Full Text] [Related]

  • 6. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.
    Litzinger DC, Huang L.
    Biochim Biophys Acta; 1992 Aug 19; 1127(3):249-54. PubMed ID: 1511002
    [Abstract] [Full Text] [Related]

  • 7. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
    Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, Iwatsuru M.
    Biochim Biophys Acta; 1992 Sep 22; 1128(1):44-9. PubMed ID: 1390877
    [Abstract] [Full Text] [Related]

  • 8. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
    Li WM, Xue L, Mayer LD, Bally MB.
    Biochim Biophys Acta; 2001 Aug 06; 1513(2):193-206. PubMed ID: 11470091
    [Abstract] [Full Text] [Related]

  • 9. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K, Kennel SJ, Huang L.
    Proc Natl Acad Sci U S A; 1990 Aug 06; 87(15):5744-8. PubMed ID: 2377612
    [Abstract] [Full Text] [Related]

  • 10. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
    Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, Karlsson G, Edwards K, Kenner G, Samuels L, Webb MS, Bally MB.
    Biochim Biophys Acta; 2007 Jun 06; 1768(6):1367-77. PubMed ID: 17400180
    [Abstract] [Full Text] [Related]

  • 11. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
    Mori A, Wu SP, Han I, Khokhar AR, Perez-Soler R, Huang L.
    Cancer Chemother Pharmacol; 1996 Jun 06; 37(5):435-44. PubMed ID: 8599866
    [Abstract] [Full Text] [Related]

  • 12. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
    Ng K, Zhao L, Liu Y, Mahapatro M.
    Int J Pharm; 2000 Jan 05; 193(2):157-66. PubMed ID: 10606778
    [Abstract] [Full Text] [Related]

  • 13. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
    Park YS, Huang L.
    J Drug Target; 1993 Jan 05; 1(4):325-30. PubMed ID: 8069575
    [Abstract] [Full Text] [Related]

  • 14. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium.
    Torchilin VP, Klibanov AL, Huang L, O'Donnell S, Nossiff ND, Khaw BA.
    FASEB J; 1992 Jun 05; 6(9):2716-9. PubMed ID: 1612296
    [Abstract] [Full Text] [Related]

  • 15. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A, Kennel SJ, Huang L.
    Pharm Res; 1993 Apr 05; 10(4):507-14. PubMed ID: 8483832
    [Abstract] [Full Text] [Related]

  • 16. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
    Moribe K, Maruyama K, Iwatsuru M.
    Chem Pharm Bull (Tokyo); 1997 Oct 05; 45(10):1683-7. PubMed ID: 9353897
    [Abstract] [Full Text] [Related]

  • 17. Influence of lipopolymer concentration on liposome degradation and blood clearance.
    Vermehren C, Jørgensen K, Frokjaer S.
    Int J Pharm; 1999 Jun 10; 183(1):13-6. PubMed ID: 10361145
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.
    Parr MJ, Ansell SM, Choi LS, Cullis PR.
    Biochim Biophys Acta; 1994 Oct 12; 1195(1):21-30. PubMed ID: 7918562
    [Abstract] [Full Text] [Related]

  • 19. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
    Biswas S, Dodwadkar NS, Sawant RR, Torchilin VP.
    Bioconjug Chem; 2011 Oct 19; 22(10):2005-13. PubMed ID: 21870873
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
    Litzinger DC, Huang L.
    Biochim Biophys Acta; 1992 Feb 17; 1104(1):179-87. PubMed ID: 1550846
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.